Long-term outcome in acute myelogenous leukemia autografted with mafosfamide-purged marrow in a single institution: adverse events and incidence of secondary myelodysplasia

We have analyzed the long-term outcome and toxicities in 98 patients with high-risk acute myelogenous leukemia (AML) who were treated with autologous bone marrow transplantation (ABMT) and monitored for a median observation period of 11.67 years. Between 1983 and 1994, 98 patients in our institution...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdallah, A, Egerer, G, Weber-Nordt, RM, Körbling, M, Haas, R, Ho, AD
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2002
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092354/
https://www.ncbi.nlm.nih.gov/pubmed/12105772
http://dx.doi.org/10.1038/sj.bmt.1703586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092354/
https://www.ncbi.nlm.nih.gov/pubmed/12105772
http://dx.doi.org/10.1038/sj.bmt.1703586

Ejemplares similares